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To the editor: Defaulting on tuberculosis (TB) treatment is one of the major barriers to effective TB control and poses serious challenge to TB control programmes. 1 The recommended targets of the World Health Organization (WHO) for TB control programmes are to achieve a case detection rate of 70% and a treatment success rate of 85%. 2 Nine of the world's 22 TB high-burden countries are in the African region and the treatment success rate in this region is said to have remained more or less unchanged at around 70% since 1998, considerably short of the 85% target. 2 Treatment default is one of the factors blamed for the low treatment success rate in the region. 2 South Africa is one of the nine TB highburden countries in Africa and the 2003 statistics for the country gave a treatment success rate of 67% among new cases and 52% among re-treatment cases, and a treatment default rate of 12%. 3 TB treatment default results in inadequate treatment of the disease, which is a major factor in the development of multi-drug resistant TB (MDR-TB). 4, 5 In 1999, MDR-TB in South Africa was estimated at 1% among new TB cases and at 4% among re-treatment TB cases. 4 The figures rose to 1.8% among new cases and 6.7% among re-treatment cases in 2004, as reported by the WHO. 3 Patients may default on TB treatment for various reasons. At Bongani TB Hospital in Mpumalanga province, South Africa, patients who are admitted for TB re-treatment because of previous treatment interruption or default are usually questioned during the admission interview about the reasons for the previous treatment default in order to provide individualised counselling and health education. This letter reports on the various reasons that the patients gave, as documented at the hospital by the author from December 2004 to December 2005.
A total number of 98 tuberculosis patients were admitted for TB re-treatment during the period. Thirty-nine (40%) of the 98 patients had defaulted on their treatment. The 39 patients were 11 (28%) females and 28 (72%) males. The ages of the female patients ranged from 19 years to 68 years, and that of the male patients from 17 years to 78 years.
The various reasons for defaulting on the previous treatment are shown in Table  I . Psycho-socio-economic issues dominated the reasons, followed by biomedical issues of TB drug side effects and inter-current illness. The findings are similar to those reported in other studies elsewhere. 6, 7 A patient-centred approach to TB management is the recommended strategy by the WHO to promote compliance with TB treatment. 1 Dick and Lombard demonstrated clearly in a study at two local authority health clinics in Cape Town, South Africa that a patient-centred interview combined with a patient education booklet significantly improved compliance with TB treatment. 8 The management of TB in South Africa is mainly done at the primary health care (PHC) level. 9 A practical way of providing a patientcentred approach to TB management in the country would be the inclusion of structured patient-centred interview guidelines and a protocol in the National TB Control Programme Guidelines for use at the PHC level, and the training of health workers at PHC clinics on the use of the interview guidelines and protocol. There is a serious need for such guidelines and protocol in view of the increasing problem of drug-resistant TB. The availability of such guidelines and protocol at the clinics would help the health workers to identify the psycho-socio-economic and biomedical issues concerning TB patients at an early stage. This would affect treatment compliance and address the issues with appropriate, individualised information, education, counselling and other necessary support to prevent treatment default. Active and practical patient-centred measures to prevent TB treatment default will go a long way to improve the TB treatment success rate and reduce the problem of drug-resistant TB in the country. Correspondence to: Dr I Upke, E-mail: ukpe@worldonline.co.za 
